toad.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
Mastodon server operated by David Troy, a tech pioneer and investigative journalist addressing threats to democracy. Thoughtful participation and discussion welcome.

Administered by:

Server stats:

297
active users

#medrxiv

0 posts0 participants0 posts today

#Preprint sites #bioRxiv and #medRxiv launch new era of independence
The popular repositories, where life #scientists post research before #peerreview, will be managed by a new organization called #openRxiv.
Until now, they had been managed by Cold Spring Harbor Laboratory. The new organization, named openRxiv, will have a board of directors and a scientific and medical advisory board. It is supported by a fresh US$16M grant from Chan Zuckerberg Initiative (CZI).
nature.com/articles/d41586-025

www.nature.comPreprint sites bioRxiv and medRxiv launch new era of independenceThe popular repositories, where scientists post research before peer review, will be managed by a new organization called openRxiv.

Another community-driven #preList is live! 🙌

A curated #preprint reading list, put together by a team of preLighters.

This list is brought to you by Chee Kiang Ewe, Mansi, Jessica Chevallier & Deevitha Balasubramanian.

Explore some excellent #genetics & #genomics preprints posted in the last few months!

#preList ⬇️👀

prelights.biologists.com/preli

preLightsEnd-of-year preprints - the genetics & genomics edition - preLights

New study: Given the publishing requirements for medical professors in #India, and given the number of future medical professors in the pipeline, it's possible to calculate that Indian medical journals cannot meet the expected author-side demand. "Thus there is a need to have a national medical #repository such as #MedRxiv to prevent publication in #predatory journals."
nmji.in/publication-requiremen

Replied in thread

@gpollara @petersuber Sciety exists to showcase public preprint review and curation. Of the 31k evaluated preprints on Sciety, 18k are from #medRxiv and you can see the numbers continue to grow in our open data lookerstudio.google.com/s/hdRd

We also want to represent preprint highlighting and the social conversation in the near term. #preprints #PeerReview

Looker StudioSciety Evaluation Activity over timeLooker Studio turns your data into informative dashboards and reports that are easy to read, easy to share, and fully customizable.

@arxiv, @biorxivpreprint, and @medrxivpreprint have released their public comments on the #OSTP #NelsonMemo.

From arXiv
info.arxiv.org/about/OSTP-04-1

From bioRxiv and medRxiv
connect.biorxiv.org/news/2023/

PS: There's a distinct echo of #Plan_U in these comments, tho without using the term. I'm glad to see it's still alive. Here's some background from 2019.
planu.org/

#arXiv, #bioRxiv, #medRxiv, #OAintheUSA, #preprints

info.arxiv.orgarXiv OSTP memorandum response - arXiv info

How well do we do social distancing? We asked this question as cognitive psychologists in our recent study. Participants in this study attempted to stand 1.5-m away from another person, and we measured the interpersonal distance they produced. (1/5)

doi.org/10.1101/2023.02.16.232
#socialdistance #preprint #medRxiv

medRxivHow well do we do social distancing?During the pandemic of coronavirus disease 2019 (COVID-19), many jurisdictions around the world introduced a 'social distance' rule under which people are instructed to keep a certain distance from others. Generally, this rule is implemented simply by telling people how many metres or feet of separation should be kept, without giving them precise instructions as to how the specified distance can be measured. Consequently, the rule is effective only to the extent that people are able to gauge this distance through their space perception. To examine the effectiveness of the rule from this point of view, the present study empirically investigated how much distance people would leave from another person when they relied on their perception of this distance. Participants (N = 153) were asked to stand exactly 1.5-m away from a researcher, and resultant interpersonal distances showed that while their mean was close to the correct 1.5-m distance, they exhibited large individual differences. These results suggest that a number of people would not stay sufficiently away from others even when they intend to do proper social distancing. Given this outcome, it is suggested that official health advice include measures that compensate for this tendency. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This study was supported by the Long Leave Research Momentum Scheme funding from Queensland University of Technology. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Office of Research Ethics and Integrity at Queensland University of Technology gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes Original data collected in this study are available on Open Science Framework at https://osf.io/zs7jv/. <https://osf.io/zs7jv/>

My boyfriend's latest paper is available now (as a pre-print) from #MedRxiv: medrxiv.org/content/10.1101/20

"In Africa, men who have sex with men face structural barriers to HIV prevention and treatment including socio-economic disadvantages, stigma, and criminalization... This systematic review explores progress towards increases in HIV testing, improving engagement in the HIV treatment cascade, and HIV incidence reductions among MSM in Africa. "

medRxivTrends in HIV testing, the treatment cascade, and HIV incidence among men who have sex with men in Africa: A systematic review and meta-regression analysisBackground Gay, bisexual, and other men who have sex with men (MSM) are disproportionately affected by HIV. In Africa, MSM face structural barriers to HIV prevention and treatment including socio-economic disadvantages, stigma, and criminalization that increase their vulnerability to HIV acquisition and transmission and undermine progress towards ending AIDS. This systematic review explores progress towards increases in HIV testing, improving engagement in the HIV treatment cascade, and HIV incidence reductions among MSM in Africa. Methods We searched Embase, Medline, Global Health, Scopus, and Web of Science from January 1980-March 2022 for cross-sectional and longitudinal studies reporting HIV testing, knowledge of status, care, antiretroviral therapy (ART) use, viral suppression, and/or HIV incidence among MSM in Africa. We pooled surveys using Bayesian generalized linear mixed-effects models, used meta-regression to assess time trends, and compared HIV incidence estimates among MSM with those of all men. Findings Of 8,992 articles identified, we included 148 unique studies published from 2005-2022. HIV testing increased over time in Central/Western and Eastern Africa and in 2020, we estimate that 88% (95% credible interval (CrI) 57-97%) of MSM had tested in the past 12 months, but 66% (19-94%) of MSM living with HIV knew their HIV status, although this is probably underestimated given non-disclosure. Current ART use increased over time in Central/Western (ORyear=1.4, 95%CrI 1.1-2.0, N=8) and Eastern/Southern Africa (ORyear=1.4, 1.0-1.8, N=17) and in 2020 we estimate that 75% (18-98%) of MSM living with HIV in Africa were currently on ART. Nevertheless, we did not find strong evidence viral suppression increased, and in 2020 we estimate that only 62% (12-95%) of MSM living with HIV were virally suppressed. HIV incidence among MSM did not decrease over time (IRRyear=1.0, 0.7-1.3, N=38) and remained high in 2020 (5.4 per 100 person-years, 0.9-33.9) and substantially higher (27-150 times higher) than among all men. Interpretation No decreases in HIV incidence have been observed among MSM in Africa over time, despite some increases in HIV testing and ART use. Achieving the UNAIDS 95-95-95 targets for diagnosis, treatment, and viral suppression equitably for all requires renewed focus on this key population. Combination interventions for MSM are urgently required to reduce disparities in HIV incidence and tackle the social, structural, and behavioural factors that make MSM vulnerable to HIV acquisition. Funding US National Institutes of Health, UK Medical Research Council, Canadian Institutes of Health Research, Fonds de Recherche du Quebec - Sante. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement We thank the HPTN Modelling Centre, which is funded by the US National Institutes of Health (NIH UM1 AI068617) through HPTN, and the GHP-MI4 Steinberg Seed Fund Grant for partial funding of this work. JS is supported by a doctoral award from the Fonds de recherche du Quebec-Sante (FRQ-S). MCB acknowledges funding from the MRC Centre for Global Infectious Disease Analysis (reference MR/R015600/1), jointly funded by the UK Medical Research Council (MRC) and the UK Foreign, Commonwealth & Development Office (FCDO), under the MRC/FCDO Concordat agreement and is also part of the EDCTP2 programme supported by the European Union. NK is supported by a career award from the Fonds de Recherche Quebec - Sante (FRQ-S; Junior 1). MM-G's research program is funded by a Canada Research Chair (Tier 2) in Population Health Modeling. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes All data produced in the present study are available upon reasonable request to the authors.